Anna Juhász

Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease

János Kálmán, Anna Juhász, G. Laird et al. · Acta Neurologica Scandinavica · 2009 · 171 citations

Medicine, Immunology, Neurology +17

Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells

Zsolt Datki, Anna Juhász, Márta Gálfi et al. · Brain Research Bulletin · 2003 · 161 citations

Pharmacy, Toxicology, Neurochemistry +5

Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease

Zsuzsanna Hartai, Anna Juhász, Ágnes Rimanóczy et al. · Neurochemistry International · 2006 · 139 citations

Medicine, Neurology, Neuroscience +10

Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia

György Szekeres, Szabolcs Kéri, Anna Juhász et al. · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 2003 · 128 citations

Medicine, Genetics, Psychiatry +17

Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer’s disease11Abbreviations used: AD, Alzheimer’s disease; Endo III, Endonuclease III; 8OHA, 8-hydroxyadenine; 8OHG, 8-hydroxyguanine; 8OHdG, 8-hydroxy-2′-deoxyguanosine; Fapy-Ade, 4,6-diamino-5-formamidopyrimidine; Fapy-Gua, 2,6,-diamino-4-hydroxy-5-formamidopyrimidine; Fpg, formamidopyrimidine glycosilase; H2O2, hydrogen-peroxide; .OH, hydroxyl radical; PBS, phosphate-buffered saline; ROS, reactive oxygen species; RT, room temperature; SSB, single strand break

Mónika Mórocz, János Kálmán, Anna Juhász et al. · Neurobiology of Aging · 2002 · 105 citations

Life Sciences, Neurobiology, Neurology +17